Multicenter clinical laboratory evaluation of a beta-lactamase disk assay employing a novel chromogenic cephalosporin, S1.
S1, a new chromogenic cephalosporin (International BioClinical, Inc., Portland, Oreg.), was used to detect beta-lactamase production among a variety of commonly encountered bacteria in a four-center collaborative study. Results of an S1 disk assay were compared with those obtained by a nitrocefin-ba...
Κύριοι συγγραφείς: | Doern, G, Jones, R, Gerlach, E, Washington, J, Biedenbach, D, Brueggemann, A, Erwin, M, Knapp, C, Raymond, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1995
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.
ανά: Winokur, P, κ.ά.
Έκδοση: (2000) -
The inhibition of metallo-beta-lactamase by thioxo-cephalosporin derivatives.
ανά: Tsang, W, κ.ά.
Έκδοση: (2004) -
Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study.
ανά: Doern, G, κ.ά.
Έκδοση: (1997) -
Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination
ανά: Hong MC, κ.ά.
Έκδοση: (2013-11-01) -
Assessment of the oxacillin disk screening test for determining penicillin resistance in Streptococcus pneumoniae.
ανά: Doern, G, κ.ά.
Έκδοση: (1997)